Ergi Kaleli is a seasoned finance professional with over 20 years of international experience in the pharmaceutical and healthcare sectors, currently serving as the Unit CFO for Global Development at UCB Pharma. In this pivotal role, Ergi is responsible for overseeing financial strategies that drive...
Ergi Kaleli is a seasoned finance professional with over 20 years of international experience in the pharmaceutical and healthcare sectors, currently serving as the Unit CFO for Global Development at UCB Pharma. In this pivotal role, Ergi is responsible for overseeing financial strategies that drive Patient Value Practices, specifically within Global Development and Medical Practices, as well as Global Strategic Marketing and Market Access Practices. His expertise as a Finance Business Partner allows him to work closely with C-suite executives, including the Chief Medical Officer and Chief Marketing Officer, ensuring that financial insights align seamlessly with strategic objectives.
Ergi's progressive track record in finance and controlling is underscored by his ability to navigate complex financial landscapes and deliver actionable insights that enhance sales effectiveness and operational efficiency. His proficiency in corporate finance and market access strategies enables him to contribute significantly to the development of innovative therapies that meet patient needs while optimizing resource allocation. By leveraging his extensive background in biotechnology and cross-functional team leadership, Ergi fosters collaboration across departments, driving initiatives that enhance the overall value proposition of UCB Pharma's offerings.
In addition to his financial acumen, Ergi is adept at managing operations and implementing strategic initiatives that support the company's long-term vision. His commitment to excellence and strategic foresight positions him as a key player in UCB Pharma's mission to deliver transformative healthcare solutions, ultimately improving patient outcomes on a global scale.
